Tran , T. B., & Doan, T. K. C. (2026). SOME RISK FACTORS OF CARDIOVASCULAR-METABOLISM AND EVALUATION OF TREATMENT RESULTS WITH EMPAGLIFLOZIN COMBINED METFORMIN IN TYPE 2 DIABETES WITH OVERWEIGHT AND OBESITY. Cantho Journal of Medicine and Pharmacy, 33, 10-16. https://tapchi.ctump.edu.vn/index.php/ctump/article/view/1181